JOHN R TESSER MD NPI 1427049220

NPI Details

John R Tesser, MD is a rheumatology internal medicine in Phoenix, AZ with 49 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. John R Tesser, MD NPI is 1427049220. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Graduation Year:1977

The provider's business location address is:

9520 W PALM LN STE 220
PHOENIX, AZ
ZIP 85037-403
Phone: (480) 443-8400
Fax: (480) 443-8697

The NPI 1427049220 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Vitamin d-3 level (HCPCS:82306)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Analysis for antibody to coccidioides (bacteria) (HCPCS:86635)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Complete ultrasound scan of joint (HCPCS:76881)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Hepatitis c antibody measurement (HCPCS:86803)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Hepatitis b core antibody (igm) measurement (HCPCS:86705)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
• Uric acid level, blood (HCPCS:84550)
• Total protein level, urine (HCPCS:84156)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose (HCPCS:J7323)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Tuberculosis test, gamma interferon (HCPCS:86480)
• Phosphate level (HCPCS:84100)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• X-ray of hand, 2 views (HCPCS:73120)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Rheumatoid factor level (HCPCS:86431)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Screening test for autoimmune disorder (HCPCS:86038)
• X-ray of knee, 3 views (HCPCS:73562)
• X-ray of chest, 2 views (HCPCS:71046)
• Fracture assessment of spine bones using dxa (HCPCS:77086)
• Dxa bone density measurement of forearm, finger, hand, or foot (HCPCS:77081)

The enumeration date for this NPI number is 10/31/2005 and was last updated on 8/19/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.